NCT06810258 BIOmarkers Before and After Kidney Transplantation
| NCT ID | NCT06810258 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Kidney Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-10-08 |
| Primary Completion | 2034-10-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-10-08 with a primary completion date of 2034-10-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In clinical nephrology, the search for urinary, blood and tissue biomarkers of specific kidney diseases is an important goal. In recent years, the use of these biomarkers has made it possible to diagnose many renal diseases that affect the native kidney. In some cases, biomarkers may be useful in determining the evolutionary profile of the disease and thus the most appropriate therapeutic management.
Eligibility Criteria
Inclusion Criteria: * Patient hospitalised for renal biopsy of a native kidney or for renal transplantation * Age \>18 years * Informed and consented * Covered by a social security scheme Exclusion criteria: * Patients under guardianship, conservatorship or legal protection * Pregnant or breastfeeding * Patient deprived of liberty * Patients of legal age who are unable to give consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06810258 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06810258 currently recruiting?
Yes, NCT06810258 is actively recruiting participants. Contact the research team at marie.matignon@aphp.fr for enrollment information.
Where is the NCT06810258 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT06810258 clinical trial?
NCT06810258 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.